Nanoscope Therapeutics Appoints Ophthalmology and Rare Disease Regulatory Leader Damon Daulerio as Executive Director of Regulatory Affairs
<p>Global regulatory affairs leader with 30 years in the pharmaceutical industry, including 28 years in regulatory affairs spanning development, registration, and lifecycle management Most recently led FDA interactions as Senior Director, Regulatory Affairs (Rare Diseases) at Insmed;...</p>
Read original article ↗
Related Articles
Updated corporate presentation details operational scale, commercial hospitality robotics deployments, and roadmap to a
Eight New Digital Asset ETPs: Valour launches eight new SEK-denominated exchange traded products on Spotlight Stock Mark
People will be able to connect their own clinical records to Healist.AI, with their consent and with cited safety checks
SiOxMed's clinical hydration science and Gifthealth's pharmacy services platform together give patients with atopic derm